Evidence map›Paper›PMID 36693777›Full record

ArticleJournal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi2023

Epidemiological investigation of the first locally acquired case of COVID-19 identified by influenza surveillance-Taiwan, February 2020.

Yang Li, Shih-Tse Huang, Wan-Chin Chen, Wan-Ting Huang, Fu-Jun Chen, Min-Tsung Lin, Du-Ling Lin, Pei-Fang Lai, Ching-Fen Ko, Chia-Ping Su

Abstract read
In one paragraph

Article in Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yang LiField Epidemiology Training Program, Taiwan Centers for Disease Control, Taipei, Taiwan; Preventive Medicine Office, Taiwan Centers for Disease Control, Taipei, Taiwan.
Shih-Tse HuangPreventive Medicine Office, Taiwan Centers for Disease Control, Taipei, Taiwan.
Wan-Chin ChenField Epidemiology Training Program, Taiwan Centers for Disease Control, Taipei, Taiwan; Preventive Medicine Office, Taiwan Centers for Disease Control, Taipei, Taiwan.
Wan-Ting HuangField Epidemiology Training Program, Taiwan Centers for Disease Control, Taipei, Taiwan; Preventive Medicine Office, Taiwan Centers for Disease Control, Taipei, Taiwan.
Fu-Jun ChenCentral Regional Center, Taiwan Centers for Disease Control, Taipei, Taiwan.
Min-Tsung LinCentral Regional Center, Taiwan Centers for Disease Control, Taipei, Taiwan.
Du-Ling LinCentral Regional Center, Taiwan Centers for Disease Control, Taipei, Taiwan.
Pei-Fang LaiCentral Regional Center, Taiwan Centers for Disease Control, Taipei, Taiwan.
Ching-Fen KoCentral Regional Center, Taiwan Centers for Disease Control, Taipei, Taiwan.
Chia-Ping SuField Epidemiology Training Program, Taiwan Centers for Disease Control, Taipei, Taiwan; Preventive Medicine Office, Taiwan Centers for Disease Control, Taipei, Taiwan. Electronic address: cpsu@cdc.gov.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 and influenza have similar clinical presentations that can range from mild to severe disease. The World Health Organization recommends that countries use existing influenza surveillance to monitor COVID-19 transmission in communities. We aim to describe the surveillance and investigation of COVID-19 at the early stage of the pandemic in Taiwan.

methodsIn February 2020, the Taiwan Centers for Disease Control enhanced COVID-19 surveillance through its existing influenza surveillance. We retrospectively tested patients for SARS-CoV-2 who had symptoms of severe complicated influenza but were negative in influenza testing. We conducted an epidemiological investigation and contact tracing for the index patient and secondary cases to prevent virus transmission.

resultsWe identified the first COVID-19 patient on February 15 through enhanced COVID-19 surveillance. He had no history of traveling abroad and an unclear history of contact with COVID-19 cases. He presented with influenza-like illness on January 27 and was hospitalized from February 3 to 15. We identified 39 close contacts of the index patient, including 11 family members and 28 healthcare workers. In total, four close family contacts of the index patient tested positive for SARS-CoV-2. An additional 84 close contacts of the four secondary cases were identified and traced; none was diagnosed with COVID-19.

conclusionsWe recommend enhancing COVID-19 surveillance by testing patients with influenza-like illness. To prevent the spread of COVID-19, we recommend using appropriate personal protective equipment when in close contact with patients who present with influenza-like illness or when caring for patients with pneumonia of unknown etiology.

Indexed as

COVID-19Influenza, HumanVirus DiseasesHumansMaleRetrospective StudiesSARS-CoV-2TaiwanContact tracingCOVID-19Epidemiological investigationInfluenza surveillanceSARS-CoV-2

Identifiers

PMID36693777
PMCPMC9840222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.